Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Post by oiljack14on Aug 14, 2020 3:23pm
275 Views
Post# 31410204

Important PMED sales fact

Important PMED sales factKeep your eye on this. He is selling Algo8 tech in India for PMED as well as Algo8 as Algo8 is the developer of all PMED tech and a large founding share-holder. This guys resume is impressive. We at Algo8 are happy to announce the leadership appointment of Amit Gupta as the Chief Sales and Marketing Officer. Amit is a former Intel executive and a senior leader with 25+ years of experience in India and Asian countries. Prior to Intel he worked with AT&T, Akamai, Star, Sprint RPG & NCSI, his last role being Sales Director at Intel in India. He has also worked in advisory board member capacity across various companies. We wish him GodSpeed at Algo8.
<< Previous
Bullboard Posts
Next >>